nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—HTR6—Alzheimer's disease	0.213	0.514	CbGaD
Amoxapine—HTR3A—Memantine—Alzheimer's disease	0.146	0.436	CbGbCtD
Amoxapine—SLC6A4—Alzheimer's disease	0.0816	0.197	CbGaD
Amoxapine—HTR2A—Donepezil—Alzheimer's disease	0.0682	0.204	CbGbCtD
Amoxapine—HTR2A—Alzheimer's disease	0.0627	0.151	CbGaD
Amoxapine—CYP2D6—Alzheimer's disease	0.0574	0.138	CbGaD
Amoxapine—DRD2—Memantine—Alzheimer's disease	0.0545	0.163	CbGbCtD
Amoxapine—CYP2D6—Rivastigmine—Alzheimer's disease	0.0284	0.085	CbGbCtD
Amoxapine—CYP2D6—Donepezil—Alzheimer's disease	0.0227	0.0679	CbGbCtD
Amoxapine—CYP2D6—Galantamine—Alzheimer's disease	0.0146	0.0438	CbGbCtD
Amoxapine—HTR2C—choroid plexus—Alzheimer's disease	0.0059	0.0886	CbGeAlD
Amoxapine—DRD3—telencephalic ventricle—Alzheimer's disease	0.00311	0.0467	CbGeAlD
Amoxapine—SLC6A2—locus ceruleus—Alzheimer's disease	0.00304	0.0457	CbGeAlD
Amoxapine—HTR2A—choroid plexus—Alzheimer's disease	0.00296	0.0445	CbGeAlD
Amoxapine—HTR7—locus ceruleus—Alzheimer's disease	0.00293	0.0441	CbGeAlD
Amoxapine—DRD1—telencephalic ventricle—Alzheimer's disease	0.00223	0.0334	CbGeAlD
Amoxapine—HTR2A—locus ceruleus—Alzheimer's disease	0.00183	0.0275	CbGeAlD
Amoxapine—HTR1B—telencephalic ventricle—Alzheimer's disease	0.0018	0.0271	CbGeAlD
Amoxapine—SLC6A3—telencephalic ventricle—Alzheimer's disease	0.00179	0.0269	CbGeAlD
Amoxapine—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00173	0.026	CbGeAlD
Amoxapine—HTR2A—cerebellar cortex—Alzheimer's disease	0.00149	0.0224	CbGeAlD
Amoxapine—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00146	0.0219	CbGeAlD
Amoxapine—HTR7—telencephalic ventricle—Alzheimer's disease	0.00139	0.0209	CbGeAlD
Amoxapine—DRD2—telencephalic ventricle—Alzheimer's disease	0.00132	0.0198	CbGeAlD
Amoxapine—HTR1B—blood vessel—Alzheimer's disease	0.000893	0.0134	CbGeAlD
Amoxapine—HTR2A—telencephalic ventricle—Alzheimer's disease	0.000868	0.013	CbGeAlD
Amoxapine—Extrapyramidal disorder—Memantine—Alzheimer's disease	0.000848	0.00772	CcSEcCtD
Amoxapine—Extrapyramidal disorder—Rivastigmine—Alzheimer's disease	0.00083	0.00755	CcSEcCtD
Amoxapine—Sensory loss—Donepezil—Alzheimer's disease	0.000812	0.00739	CcSEcCtD
Amoxapine—HTR6—forebrain—Alzheimer's disease	0.000782	0.0117	CbGeAlD
Amoxapine—Numbness—Memantine—Alzheimer's disease	0.000771	0.00701	CcSEcCtD
Amoxapine—Disturbance in attention—Memantine—Alzheimer's disease	0.000738	0.00671	CcSEcCtD
Amoxapine—Sensory loss—Memantine—Alzheimer's disease	0.000738	0.00671	CcSEcCtD
Amoxapine—Vascular purpura—Galantamine—Alzheimer's disease	0.000737	0.00671	CcSEcCtD
Amoxapine—Atrioventricular block—Donepezil—Alzheimer's disease	0.000725	0.0066	CcSEcCtD
Amoxapine—Disturbance in attention—Rivastigmine—Alzheimer's disease	0.000721	0.00657	CcSEcCtD
Amoxapine—HTR6—telencephalon—Alzheimer's disease	0.000719	0.0108	CbGeAlD
Amoxapine—Atrial fibrillation—Galantamine—Alzheimer's disease	0.000696	0.00633	CcSEcCtD
Amoxapine—HTR7—blood vessel—Alzheimer's disease	0.000689	0.0103	CbGeAlD
Amoxapine—Purpura—Galantamine—Alzheimer's disease	0.000684	0.00622	CcSEcCtD
Amoxapine—Cerebrovascular accident—Galantamine—Alzheimer's disease	0.000673	0.00612	CcSEcCtD
Amoxapine—Atrioventricular block—Memantine—Alzheimer's disease	0.000659	0.00599	CcSEcCtD
Amoxapine—Disturbance in sexual arousal—Galantamine—Alzheimer's disease	0.000654	0.00595	CcSEcCtD
Amoxapine—Coordination abnormal—Memantine—Alzheimer's disease	0.000651	0.00592	CcSEcCtD
Amoxapine—Atrioventricular block—Rivastigmine—Alzheimer's disease	0.000644	0.00586	CcSEcCtD
Amoxapine—Vasculitis—Rivastigmine—Alzheimer's disease	0.00064	0.00583	CcSEcCtD
Amoxapine—Coordination abnormal—Rivastigmine—Alzheimer's disease	0.000636	0.00579	CcSEcCtD
Amoxapine—Urinary retention—Galantamine—Alzheimer's disease	0.000627	0.0057	CcSEcCtD
Amoxapine—Ataxia—Galantamine—Alzheimer's disease	0.00062	0.00564	CcSEcCtD
Amoxapine—Nightmare—Memantine—Alzheimer's disease	0.000617	0.00561	CcSEcCtD
Amoxapine—Nightmare—Rivastigmine—Alzheimer's disease	0.000604	0.00549	CcSEcCtD
Amoxapine—DRD1—forebrain—Alzheimer's disease	0.000581	0.00873	CbGeAlD
Amoxapine—HTR3A—forebrain—Alzheimer's disease	0.000562	0.00843	CbGeAlD
Amoxapine—Mental disability—Memantine—Alzheimer's disease	0.000554	0.00505	CcSEcCtD
Amoxapine—Libido decreased—Donepezil—Alzheimer's disease	0.000551	0.00501	CcSEcCtD
Amoxapine—Increased appetite—Donepezil—Alzheimer's disease	0.000544	0.00495	CcSEcCtD
Amoxapine—Mental disability—Rivastigmine—Alzheimer's disease	0.000542	0.00494	CcSEcCtD
Amoxapine—Atrial fibrillation—Donepezil—Alzheimer's disease	0.000539	0.00491	CcSEcCtD
Amoxapine—DRD1—telencephalon—Alzheimer's disease	0.000535	0.00803	CbGeAlD
Amoxapine—Pollakiuria—Galantamine—Alzheimer's disease	0.000526	0.00479	CcSEcCtD
Amoxapine—Cerebrovascular accident—Donepezil—Alzheimer's disease	0.000521	0.00474	CcSEcCtD
Amoxapine—Disorientation—Memantine—Alzheimer's disease	0.000518	0.00472	CcSEcCtD
Amoxapine—Vascular purpura—Memantine—Alzheimer's disease	0.000518	0.00472	CcSEcCtD
Amoxapine—HTR3A—telencephalon—Alzheimer's disease	0.000516	0.00775	CbGeAlD
Amoxapine—Asenapine—HTR6—Alzheimer's disease	0.000508	0.157	CrCbGaD
Amoxapine—Vascular purpura—Rivastigmine—Alzheimer's disease	0.000507	0.00462	CcSEcCtD
Amoxapine—Disturbance in sexual arousal—Donepezil—Alzheimer's disease	0.000507	0.00461	CcSEcCtD
Amoxapine—Libido decreased—Memantine—Alzheimer's disease	0.0005	0.00455	CcSEcCtD
Amoxapine—Increased appetite—Memantine—Alzheimer's disease	0.000494	0.00449	CcSEcCtD
Amoxapine—Atrial fibrillation—Memantine—Alzheimer's disease	0.000489	0.00445	CcSEcCtD
Amoxapine—Libido decreased—Rivastigmine—Alzheimer's disease	0.000489	0.00445	CcSEcCtD
Amoxapine—Urinary retention—Donepezil—Alzheimer's disease	0.000486	0.00442	CcSEcCtD
Amoxapine—Increased appetite—Rivastigmine—Alzheimer's disease	0.000483	0.0044	CcSEcCtD
Amoxapine—Purpura—Memantine—Alzheimer's disease	0.000481	0.00438	CcSEcCtD
Amoxapine—Ataxia—Donepezil—Alzheimer's disease	0.00048	0.00437	CcSEcCtD
Amoxapine—DRD4—brain—Alzheimer's disease	0.000479	0.0072	CbGeAlD
Amoxapine—Atrial fibrillation—Rivastigmine—Alzheimer's disease	0.000479	0.00436	CcSEcCtD
Amoxapine—Cerebrovascular accident—Memantine—Alzheimer's disease	0.000473	0.00431	CcSEcCtD
Amoxapine—HTR1B—forebrain—Alzheimer's disease	0.000471	0.00707	CbGeAlD
Amoxapine—GABRA1—forebrain—Alzheimer's disease	0.000471	0.00707	CbGeAlD
Amoxapine—Purpura—Rivastigmine—Alzheimer's disease	0.000471	0.00428	CcSEcCtD
Amoxapine—SLC6A3—forebrain—Alzheimer's disease	0.000467	0.00702	CbGeAlD
Amoxapine—Cerebrovascular accident—Rivastigmine—Alzheimer's disease	0.000463	0.00421	CcSEcCtD
Amoxapine—Disturbance in sexual arousal—Memantine—Alzheimer's disease	0.00046	0.00419	CcSEcCtD
Amoxapine—Hepatitis—Galantamine—Alzheimer's disease	0.000456	0.00415	CcSEcCtD
Amoxapine—Hallucination—Galantamine—Alzheimer's disease	0.000454	0.00413	CcSEcCtD
Amoxapine—HTR2C—forebrain—Alzheimer's disease	0.000452	0.00678	CbGeAlD
Amoxapine—Disturbance in sexual arousal—Rivastigmine—Alzheimer's disease	0.00045	0.0041	CcSEcCtD
Amoxapine—Urinary retention—Memantine—Alzheimer's disease	0.000441	0.00401	CcSEcCtD
Amoxapine—DRD3—nervous system—Alzheimer's disease	0.000441	0.00662	CbGeAlD
Amoxapine—Eosinophilia—Donepezil—Alzheimer's disease	0.000437	0.00398	CcSEcCtD
Amoxapine—Ataxia—Memantine—Alzheimer's disease	0.000436	0.00397	CcSEcCtD
Amoxapine—HTR1B—telencephalon—Alzheimer's disease	0.000433	0.0065	CbGeAlD
Amoxapine—GABRA1—telencephalon—Alzheimer's disease	0.000433	0.0065	CbGeAlD
Amoxapine—Pancreatitis—Donepezil—Alzheimer's disease	0.000433	0.00394	CcSEcCtD
Amoxapine—Urinary retention—Rivastigmine—Alzheimer's disease	0.000431	0.00393	CcSEcCtD
Amoxapine—SLC6A3—telencephalon—Alzheimer's disease	0.00043	0.00645	CbGeAlD
Amoxapine—HTR2A—blood vessel—Alzheimer's disease	0.00043	0.00645	CbGeAlD
Amoxapine—SLC6A4—forebrain—Alzheimer's disease	0.000428	0.00643	CbGeAlD
Amoxapine—Ataxia—Rivastigmine—Alzheimer's disease	0.000427	0.00388	CcSEcCtD
Amoxapine—CHRM1—forebrain—Alzheimer's disease	0.000427	0.0064	CbGeAlD
Amoxapine—Tinnitus—Galantamine—Alzheimer's disease	0.000425	0.00387	CcSEcCtD
Amoxapine—DRD3—central nervous system—Alzheimer's disease	0.000424	0.00637	CbGeAlD
Amoxapine—HTR6—nervous system—Alzheimer's disease	0.000424	0.00637	CbGeAlD
Amoxapine—HTR2B—forebrain—Alzheimer's disease	0.000424	0.00637	CbGeAlD
Amoxapine—HTR2C—telencephalon—Alzheimer's disease	0.000415	0.00624	CbGeAlD
Amoxapine—HTR6—central nervous system—Alzheimer's disease	0.000409	0.00613	CbGeAlD
Amoxapine—Pollakiuria—Donepezil—Alzheimer's disease	0.000408	0.00371	CcSEcCtD
Amoxapine—Weight increased—Donepezil—Alzheimer's disease	0.000402	0.00366	CcSEcCtD
Amoxapine—SLC6A4—telencephalon—Alzheimer's disease	0.000394	0.00591	CbGeAlD
Amoxapine—Pancreatitis—Memantine—Alzheimer's disease	0.000393	0.00358	CcSEcCtD
Amoxapine—CHRM1—telencephalon—Alzheimer's disease	0.000392	0.00589	CbGeAlD
Amoxapine—Flatulence—Galantamine—Alzheimer's disease	0.000391	0.00356	CcSEcCtD
Amoxapine—HTR2B—telencephalon—Alzheimer's disease	0.00039	0.00586	CbGeAlD
Amoxapine—Tension—Galantamine—Alzheimer's disease	0.000389	0.00354	CcSEcCtD
Amoxapine—Dysgeusia—Galantamine—Alzheimer's disease	0.000389	0.00354	CcSEcCtD
Amoxapine—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000388	0.00353	CcSEcCtD
Amoxapine—Myocardial infarction—Donepezil—Alzheimer's disease	0.000386	0.00351	CcSEcCtD
Amoxapine—Nervousness—Galantamine—Alzheimer's disease	0.000386	0.00351	CcSEcCtD
Amoxapine—Pancreatitis—Rivastigmine—Alzheimer's disease	0.000384	0.0035	CcSEcCtD
Amoxapine—Jaundice—Donepezil—Alzheimer's disease	0.000384	0.00349	CcSEcCtD
Amoxapine—HTR1A—forebrain—Alzheimer's disease	0.00038	0.00571	CbGeAlD
Amoxapine—SLC6A2—forebrain—Alzheimer's disease	0.000377	0.00566	CbGeAlD
Amoxapine—Vision blurred—Galantamine—Alzheimer's disease	0.000374	0.0034	CcSEcCtD
Amoxapine—Tremor—Galantamine—Alzheimer's disease	0.000372	0.00338	CcSEcCtD
Amoxapine—Pollakiuria—Memantine—Alzheimer's disease	0.00037	0.00337	CcSEcCtD
Amoxapine—Erectile dysfunction—Memantine—Alzheimer's disease	0.000369	0.00336	CcSEcCtD
Amoxapine—Weight increased—Memantine—Alzheimer's disease	0.000365	0.00332	CcSEcCtD
Amoxapine—Agitation—Galantamine—Alzheimer's disease	0.000365	0.00332	CcSEcCtD
Amoxapine—HTR7—forebrain—Alzheimer's disease	0.000363	0.00546	CbGeAlD
Amoxapine—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000362	0.0033	CcSEcCtD
Amoxapine—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000361	0.00329	CcSEcCtD
Amoxapine—Weight increased—Rivastigmine—Alzheimer's disease	0.000357	0.00325	CcSEcCtD
Amoxapine—Syncope—Galantamine—Alzheimer's disease	0.000356	0.00324	CcSEcCtD
Amoxapine—Hepatitis—Donepezil—Alzheimer's disease	0.000353	0.00322	CcSEcCtD
Amoxapine—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000352	0.00321	CcSEcCtD
Amoxapine—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000352	0.0032	CcSEcCtD
Amoxapine—Hallucination—Donepezil—Alzheimer's disease	0.000352	0.0032	CcSEcCtD
Amoxapine—Palpitations—Galantamine—Alzheimer's disease	0.000351	0.00319	CcSEcCtD
Amoxapine—ADRA1A—forebrain—Alzheimer's disease	0.00035	0.00526	CbGeAlD
Amoxapine—Myocardial infarction—Memantine—Alzheimer's disease	0.00035	0.00319	CcSEcCtD
Amoxapine—Drowsiness—Rivastigmine—Alzheimer's disease	0.00035	0.00318	CcSEcCtD
Amoxapine—HTR1A—telencephalon—Alzheimer's disease	0.00035	0.00525	CbGeAlD
Amoxapine—Loss of consciousness—Galantamine—Alzheimer's disease	0.000349	0.00318	CcSEcCtD
Amoxapine—SLC6A2—telencephalon—Alzheimer's disease	0.000347	0.0052	CbGeAlD
Amoxapine—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000345	0.00314	CcSEcCtD
Amoxapine—Convulsion—Galantamine—Alzheimer's disease	0.000344	0.00313	CcSEcCtD
Amoxapine—DRD2—forebrain—Alzheimer's disease	0.000344	0.00516	CbGeAlD
Amoxapine—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000343	0.00312	CcSEcCtD
Amoxapine—Hypertension—Galantamine—Alzheimer's disease	0.000343	0.00312	CcSEcCtD
Amoxapine—DRD3—brain—Alzheimer's disease	0.000337	0.00506	CbGeAlD
Amoxapine—HTR7—telencephalon—Alzheimer's disease	0.000334	0.00502	CbGeAlD
Amoxapine—Agranulocytosis—Memantine—Alzheimer's disease	0.000334	0.00304	CcSEcCtD
Amoxapine—Dry mouth—Galantamine—Alzheimer's disease	0.00033	0.00301	CcSEcCtD
Amoxapine—Tinnitus—Donepezil—Alzheimer's disease	0.000329	0.003	CcSEcCtD
Amoxapine—Confusional state—Galantamine—Alzheimer's disease	0.000327	0.00297	CcSEcCtD
Amoxapine—HTR6—brain—Alzheimer's disease	0.000324	0.00487	CbGeAlD
Amoxapine—ADRA1A—telencephalon—Alzheimer's disease	0.000322	0.00484	CbGeAlD
Amoxapine—Hepatitis—Memantine—Alzheimer's disease	0.000321	0.00292	CcSEcCtD
Amoxapine—Hallucination—Memantine—Alzheimer's disease	0.000319	0.00291	CcSEcCtD
Amoxapine—Hypoaesthesia—Memantine—Alzheimer's disease	0.000319	0.00291	CcSEcCtD
Amoxapine—Shock—Galantamine—Alzheimer's disease	0.000319	0.0029	CcSEcCtD
Amoxapine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000317	0.00289	CcSEcCtD
Amoxapine—Tachycardia—Galantamine—Alzheimer's disease	0.000316	0.00288	CcSEcCtD
Amoxapine—DRD2—telencephalon—Alzheimer's disease	0.000316	0.00474	CbGeAlD
Amoxapine—DRD1—nervous system—Alzheimer's disease	0.000316	0.00474	CbGeAlD
Amoxapine—Hepatitis—Rivastigmine—Alzheimer's disease	0.000314	0.00286	CcSEcCtD
Amoxapine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000312	0.00284	CcSEcCtD
Amoxapine—Hallucination—Rivastigmine—Alzheimer's disease	0.000312	0.00284	CcSEcCtD
Amoxapine—Alopecia—Donepezil—Alzheimer's disease	0.000312	0.00284	CcSEcCtD
Amoxapine—Anorexia—Galantamine—Alzheimer's disease	0.000309	0.00281	CcSEcCtD
Amoxapine—HTR3A—nervous system—Alzheimer's disease	0.000305	0.00458	CbGeAlD
Amoxapine—DRD1—central nervous system—Alzheimer's disease	0.000304	0.00456	CbGeAlD
Amoxapine—Flatulence—Donepezil—Alzheimer's disease	0.000303	0.00276	CcSEcCtD
Amoxapine—Hypotension—Galantamine—Alzheimer's disease	0.000303	0.00275	CcSEcCtD
Amoxapine—Tension—Donepezil—Alzheimer's disease	0.000302	0.00275	CcSEcCtD
Amoxapine—Dysgeusia—Donepezil—Alzheimer's disease	0.000301	0.00274	CcSEcCtD
Amoxapine—Tinnitus—Memantine—Alzheimer's disease	0.000299	0.00272	CcSEcCtD
Amoxapine—Nervousness—Donepezil—Alzheimer's disease	0.000299	0.00272	CcSEcCtD
Amoxapine—Zuclopenthixol—HTR6—Alzheimer's disease	0.000297	0.092	CrCbGaD
Amoxapine—HTR3A—central nervous system—Alzheimer's disease	0.000294	0.00441	CbGeAlD
Amoxapine—Insomnia—Galantamine—Alzheimer's disease	0.000293	0.00267	CcSEcCtD
Amoxapine—Tinnitus—Rivastigmine—Alzheimer's disease	0.000293	0.00266	CcSEcCtD
Amoxapine—Paraesthesia—Galantamine—Alzheimer's disease	0.000291	0.00265	CcSEcCtD
Amoxapine—Vision blurred—Donepezil—Alzheimer's disease	0.00029	0.00264	CcSEcCtD
Amoxapine—Tremor—Donepezil—Alzheimer's disease	0.000288	0.00262	CcSEcCtD
Amoxapine—Somnolence—Galantamine—Alzheimer's disease	0.000288	0.00262	CcSEcCtD
Amoxapine—Dyspepsia—Galantamine—Alzheimer's disease	0.000285	0.0026	CcSEcCtD
Amoxapine—Alopecia—Memantine—Alzheimer's disease	0.000284	0.00258	CcSEcCtD
Amoxapine—Olanzapine—HTR6—Alzheimer's disease	0.000283	0.0876	CrCbGaD
Amoxapine—Agitation—Donepezil—Alzheimer's disease	0.000283	0.00257	CcSEcCtD
Amoxapine—Decreased appetite—Galantamine—Alzheimer's disease	0.000282	0.00256	CcSEcCtD
Amoxapine—Fatigue—Galantamine—Alzheimer's disease	0.000279	0.00254	CcSEcCtD
Amoxapine—Alopecia—Rivastigmine—Alzheimer's disease	0.000277	0.00252	CcSEcCtD
Amoxapine—Constipation—Galantamine—Alzheimer's disease	0.000277	0.00252	CcSEcCtD
Amoxapine—Syncope—Donepezil—Alzheimer's disease	0.000276	0.00251	CcSEcCtD
Amoxapine—Flatulence—Memantine—Alzheimer's disease	0.000275	0.0025	CcSEcCtD
Amoxapine—Tension—Memantine—Alzheimer's disease	0.000274	0.00249	CcSEcCtD
Amoxapine—Dysgeusia—Memantine—Alzheimer's disease	0.000274	0.00249	CcSEcCtD
Amoxapine—ORM1—nervous system—Alzheimer's disease	0.000273	0.0041	CbGeAlD
Amoxapine—HRH1—forebrain—Alzheimer's disease	0.000271	0.00407	CbGeAlD
Amoxapine—Nervousness—Memantine—Alzheimer's disease	0.000271	0.00247	CcSEcCtD
Amoxapine—Loss of consciousness—Donepezil—Alzheimer's disease	0.00027	0.00246	CcSEcCtD
Amoxapine—Flatulence—Rivastigmine—Alzheimer's disease	0.000269	0.00245	CcSEcCtD
Amoxapine—Tension—Rivastigmine—Alzheimer's disease	0.000268	0.00244	CcSEcCtD
Amoxapine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000268	0.00244	CcSEcCtD
Amoxapine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000267	0.00243	CcSEcCtD
Amoxapine—Convulsion—Donepezil—Alzheimer's disease	0.000267	0.00243	CcSEcCtD
Amoxapine—ADRA2A—forebrain—Alzheimer's disease	0.000266	0.004	CbGeAlD
Amoxapine—Hypertension—Donepezil—Alzheimer's disease	0.000266	0.00242	CcSEcCtD
Amoxapine—Nervousness—Rivastigmine—Alzheimer's disease	0.000265	0.00242	CcSEcCtD
Amoxapine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000265	0.00241	CcSEcCtD
Amoxapine—Vision blurred—Memantine—Alzheimer's disease	0.000263	0.0024	CcSEcCtD
Amoxapine—ORM1—central nervous system—Alzheimer's disease	0.000263	0.00394	CbGeAlD
Amoxapine—Tremor—Memantine—Alzheimer's disease	0.000262	0.00238	CcSEcCtD
Amoxapine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000258	0.00234	CcSEcCtD
Amoxapine—Agitation—Memantine—Alzheimer's disease	0.000257	0.00234	CcSEcCtD
Amoxapine—HTR2A—embryo—Alzheimer's disease	0.000256	0.00385	CbGeAlD
Amoxapine—Dry mouth—Donepezil—Alzheimer's disease	0.000256	0.00233	CcSEcCtD
Amoxapine—Abdominal pain—Galantamine—Alzheimer's disease	0.000256	0.00233	CcSEcCtD
Amoxapine—Body temperature increased—Galantamine—Alzheimer's disease	0.000256	0.00233	CcSEcCtD
Amoxapine—Tremor—Rivastigmine—Alzheimer's disease	0.000256	0.00233	CcSEcCtD
Amoxapine—HTR1B—nervous system—Alzheimer's disease	0.000256	0.00384	CbGeAlD
Amoxapine—GABRA1—nervous system—Alzheimer's disease	0.000256	0.00384	CbGeAlD
Amoxapine—SLC6A3—nervous system—Alzheimer's disease	0.000254	0.00381	CbGeAlD
Amoxapine—Confusional state—Donepezil—Alzheimer's disease	0.000253	0.0023	CcSEcCtD
Amoxapine—Agitation—Rivastigmine—Alzheimer's disease	0.000251	0.00229	CcSEcCtD
Amoxapine—Oedema—Donepezil—Alzheimer's disease	0.000251	0.00228	CcSEcCtD
Amoxapine—Syncope—Memantine—Alzheimer's disease	0.00025	0.00228	CcSEcCtD
Amoxapine—Leukopenia—Memantine—Alzheimer's disease	0.00025	0.00228	CcSEcCtD
Amoxapine—HRH1—telencephalon—Alzheimer's disease	0.000249	0.00375	CbGeAlD
Amoxapine—Shock—Donepezil—Alzheimer's disease	0.000247	0.00225	CcSEcCtD
Amoxapine—Palpitations—Memantine—Alzheimer's disease	0.000247	0.00225	CcSEcCtD
Amoxapine—HTR1B—central nervous system—Alzheimer's disease	0.000246	0.0037	CbGeAlD
Amoxapine—GABRA1—central nervous system—Alzheimer's disease	0.000246	0.0037	CbGeAlD
Amoxapine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000246	0.00224	CcSEcCtD
Amoxapine—Loss of consciousness—Memantine—Alzheimer's disease	0.000245	0.00223	CcSEcCtD
Amoxapine—HTR2C—nervous system—Alzheimer's disease	0.000245	0.00368	CbGeAlD
Amoxapine—ADRA2A—telencephalon—Alzheimer's disease	0.000245	0.00368	CbGeAlD
Amoxapine—Syncope—Rivastigmine—Alzheimer's disease	0.000245	0.00223	CcSEcCtD
Amoxapine—SLC6A3—central nervous system—Alzheimer's disease	0.000244	0.00367	CbGeAlD
Amoxapine—Convulsion—Memantine—Alzheimer's disease	0.000242	0.0022	CcSEcCtD
Amoxapine—Palpitations—Rivastigmine—Alzheimer's disease	0.000241	0.0022	CcSEcCtD
Amoxapine—DRD1—brain—Alzheimer's disease	0.000241	0.00362	CbGeAlD
Amoxapine—Hypertension—Memantine—Alzheimer's disease	0.000241	0.00219	CcSEcCtD
Amoxapine—GABRA1—cerebellum—Alzheimer's disease	0.000241	0.00361	CbGeAlD
Amoxapine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00024	0.00219	CcSEcCtD
Amoxapine—Anorexia—Donepezil—Alzheimer's disease	0.000239	0.00218	CcSEcCtD
Amoxapine—SLC6A3—cerebellum—Alzheimer's disease	0.000239	0.00358	CbGeAlD
Amoxapine—Convulsion—Rivastigmine—Alzheimer's disease	0.000237	0.00215	CcSEcCtD
Amoxapine—HTR2C—central nervous system—Alzheimer's disease	0.000236	0.00354	CbGeAlD
Amoxapine—Hypertension—Rivastigmine—Alzheimer's disease	0.000236	0.00215	CcSEcCtD
Amoxapine—Hypotension—Donepezil—Alzheimer's disease	0.000235	0.00214	CcSEcCtD
Amoxapine—HTR3A—brain—Alzheimer's disease	0.000233	0.0035	CbGeAlD
Amoxapine—Dry mouth—Memantine—Alzheimer's disease	0.000233	0.00212	CcSEcCtD
Amoxapine—SLC6A4—nervous system—Alzheimer's disease	0.000232	0.00349	CbGeAlD
Amoxapine—Asthenia—Galantamine—Alzheimer's disease	0.000232	0.00212	CcSEcCtD
Amoxapine—CHRM1—nervous system—Alzheimer's disease	0.000232	0.00348	CbGeAlD
Amoxapine—HTR2B—nervous system—Alzheimer's disease	0.00023	0.00346	CbGeAlD
Amoxapine—Confusional state—Memantine—Alzheimer's disease	0.00023	0.00209	CcSEcCtD
Amoxapine—Oedema—Memantine—Alzheimer's disease	0.000228	0.00207	CcSEcCtD
Amoxapine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000228	0.00207	CcSEcCtD
Amoxapine—Insomnia—Donepezil—Alzheimer's disease	0.000227	0.00207	CcSEcCtD
Amoxapine—HTR2A—forebrain—Alzheimer's disease	0.000227	0.0034	CbGeAlD
Amoxapine—Paraesthesia—Donepezil—Alzheimer's disease	0.000225	0.00205	CcSEcCtD
Amoxapine—Confusional state—Rivastigmine—Alzheimer's disease	0.000225	0.00205	CcSEcCtD
Amoxapine—Shock—Memantine—Alzheimer's disease	0.000224	0.00204	CcSEcCtD
Amoxapine—SLC6A4—central nervous system—Alzheimer's disease	0.000224	0.00336	CbGeAlD
Amoxapine—Somnolence—Donepezil—Alzheimer's disease	0.000223	0.00203	CcSEcCtD
Amoxapine—Thrombocytopenia—Memantine—Alzheimer's disease	0.000223	0.00203	CcSEcCtD
Amoxapine—Oedema—Rivastigmine—Alzheimer's disease	0.000223	0.00203	CcSEcCtD
Amoxapine—CHRM1—central nervous system—Alzheimer's disease	0.000223	0.00335	CbGeAlD
Amoxapine—Tachycardia—Memantine—Alzheimer's disease	0.000222	0.00202	CcSEcCtD
Amoxapine—HTR2B—central nervous system—Alzheimer's disease	0.000222	0.00333	CbGeAlD
Amoxapine—Diarrhoea—Galantamine—Alzheimer's disease	0.000222	0.00202	CcSEcCtD
Amoxapine—Dyspepsia—Donepezil—Alzheimer's disease	0.000221	0.00201	CcSEcCtD
Amoxapine—Shock—Rivastigmine—Alzheimer's disease	0.000219	0.002	CcSEcCtD
Amoxapine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000218	0.00199	CcSEcCtD
Amoxapine—Decreased appetite—Donepezil—Alzheimer's disease	0.000218	0.00199	CcSEcCtD
Amoxapine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000218	0.00198	CcSEcCtD
Amoxapine—Anorexia—Memantine—Alzheimer's disease	0.000217	0.00198	CcSEcCtD
Amoxapine—Fatigue—Donepezil—Alzheimer's disease	0.000216	0.00197	CcSEcCtD
Amoxapine—Constipation—Donepezil—Alzheimer's disease	0.000215	0.00195	CcSEcCtD
Amoxapine—Dizziness—Galantamine—Alzheimer's disease	0.000214	0.00195	CcSEcCtD
Amoxapine—Hypotension—Memantine—Alzheimer's disease	0.000213	0.00194	CcSEcCtD
Amoxapine—Anorexia—Rivastigmine—Alzheimer's disease	0.000213	0.00193	CcSEcCtD
Amoxapine—Desloratadine—CYP2D6—Alzheimer's disease	0.000212	0.0657	CrCbGaD
Amoxapine—Hypotension—Rivastigmine—Alzheimer's disease	0.000208	0.0019	CcSEcCtD
Amoxapine—HTR2A—telencephalon—Alzheimer's disease	0.000208	0.00313	CbGeAlD
Amoxapine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000207	0.00188	CcSEcCtD
Amoxapine—CYP2D6—forebrain—Alzheimer's disease	0.000206	0.0031	CbGeAlD
Amoxapine—HTR1A—nervous system—Alzheimer's disease	0.000206	0.0031	CbGeAlD
Amoxapine—Insomnia—Memantine—Alzheimer's disease	0.000206	0.00188	CcSEcCtD
Amoxapine—Vomiting—Galantamine—Alzheimer's disease	0.000206	0.00187	CcSEcCtD
Amoxapine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000205	0.00187	CcSEcCtD
Amoxapine—Paraesthesia—Memantine—Alzheimer's disease	0.000205	0.00186	CcSEcCtD
Amoxapine—SLC6A2—nervous system—Alzheimer's disease	0.000205	0.00307	CbGeAlD
Amoxapine—Rash—Galantamine—Alzheimer's disease	0.000204	0.00186	CcSEcCtD
Amoxapine—Dermatitis—Galantamine—Alzheimer's disease	0.000204	0.00186	CcSEcCtD
Amoxapine—Headache—Galantamine—Alzheimer's disease	0.000203	0.00185	CcSEcCtD
Amoxapine—Somnolence—Memantine—Alzheimer's disease	0.000203	0.00184	CcSEcCtD
Amoxapine—Insomnia—Rivastigmine—Alzheimer's disease	0.000202	0.00184	CcSEcCtD
Amoxapine—Dyspepsia—Memantine—Alzheimer's disease	0.000201	0.00183	CcSEcCtD
Amoxapine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.0002	0.00182	CcSEcCtD
Amoxapine—Urticaria—Donepezil—Alzheimer's disease	0.000199	0.00182	CcSEcCtD
Amoxapine—HTR1A—central nervous system—Alzheimer's disease	0.000199	0.00298	CbGeAlD
Amoxapine—Body temperature increased—Donepezil—Alzheimer's disease	0.000198	0.00181	CcSEcCtD
Amoxapine—Abdominal pain—Donepezil—Alzheimer's disease	0.000198	0.00181	CcSEcCtD
Amoxapine—Somnolence—Rivastigmine—Alzheimer's disease	0.000198	0.0018	CcSEcCtD
Amoxapine—Decreased appetite—Memantine—Alzheimer's disease	0.000198	0.0018	CcSEcCtD
Amoxapine—HTR7—nervous system—Alzheimer's disease	0.000197	0.00296	CbGeAlD
Amoxapine—SLC6A2—central nervous system—Alzheimer's disease	0.000197	0.00296	CbGeAlD
Amoxapine—Fatigue—Memantine—Alzheimer's disease	0.000197	0.00179	CcSEcCtD
Amoxapine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000196	0.00179	CcSEcCtD
Amoxapine—HTR1B—brain—Alzheimer's disease	0.000196	0.00294	CbGeAlD
Amoxapine—GABRA1—brain—Alzheimer's disease	0.000196	0.00294	CbGeAlD
Amoxapine—Constipation—Memantine—Alzheimer's disease	0.000195	0.00177	CcSEcCtD
Amoxapine—Asenapine—SLC6A4—Alzheimer's disease	0.000195	0.0603	CrCbGaD
Amoxapine—HTR1A—cerebellum—Alzheimer's disease	0.000194	0.00292	CbGeAlD
Amoxapine—SLC6A3—brain—Alzheimer's disease	0.000194	0.00291	CbGeAlD
Amoxapine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000194	0.00176	CcSEcCtD
Amoxapine—Nausea—Galantamine—Alzheimer's disease	0.000192	0.00175	CcSEcCtD
Amoxapine—Fatigue—Rivastigmine—Alzheimer's disease	0.000192	0.00175	CcSEcCtD
Amoxapine—Constipation—Rivastigmine—Alzheimer's disease	0.000191	0.00174	CcSEcCtD
Amoxapine—ADRA1A—nervous system—Alzheimer's disease	0.00019	0.00286	CbGeAlD
Amoxapine—HTR7—central nervous system—Alzheimer's disease	0.00019	0.00285	CbGeAlD
Amoxapine—CYP2D6—telencephalon—Alzheimer's disease	0.00019	0.00285	CbGeAlD
Amoxapine—Feeling abnormal—Memantine—Alzheimer's disease	0.000188	0.00171	CcSEcCtD
Amoxapine—HTR2C—brain—Alzheimer's disease	0.000187	0.00281	CbGeAlD
Amoxapine—Mazindol—SLC6A4—Alzheimer's disease	0.000187	0.0578	CrCbGaD
Amoxapine—DRD2—nervous system—Alzheimer's disease	0.000187	0.0028	CbGeAlD
Amoxapine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000186	0.0017	CcSEcCtD
Amoxapine—HTR7—cerebellum—Alzheimer's disease	0.000186	0.00279	CbGeAlD
Amoxapine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000184	0.00167	CcSEcCtD
Amoxapine—ADRA1A—central nervous system—Alzheimer's disease	0.000183	0.00275	CbGeAlD
Amoxapine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000182	0.00166	CcSEcCtD
Amoxapine—Urticaria—Memantine—Alzheimer's disease	0.000181	0.00165	CcSEcCtD
Amoxapine—Body temperature increased—Memantine—Alzheimer's disease	0.00018	0.00164	CcSEcCtD
Amoxapine—Abdominal pain—Memantine—Alzheimer's disease	0.00018	0.00164	CcSEcCtD
Amoxapine—Asthenia—Donepezil—Alzheimer's disease	0.00018	0.00164	CcSEcCtD
Amoxapine—DRD2—central nervous system—Alzheimer's disease	0.00018	0.0027	CbGeAlD
Amoxapine—ADRA1A—cerebellum—Alzheimer's disease	0.000179	0.00269	CbGeAlD
Amoxapine—SLC6A4—brain—Alzheimer's disease	0.000178	0.00267	CbGeAlD
Amoxapine—Pruritus—Donepezil—Alzheimer's disease	0.000178	0.00162	CcSEcCtD
Amoxapine—Urticaria—Rivastigmine—Alzheimer's disease	0.000177	0.00161	CcSEcCtD
Amoxapine—CHRM1—brain—Alzheimer's disease	0.000177	0.00266	CbGeAlD
Amoxapine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000176	0.0016	CcSEcCtD
Amoxapine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000176	0.0016	CcSEcCtD
Amoxapine—HTR2B—brain—Alzheimer's disease	0.000176	0.00264	CbGeAlD
Amoxapine—Loxapine—HTR6—Alzheimer's disease	0.000176	0.0544	CrCbGaD
Amoxapine—DRD2—cerebellum—Alzheimer's disease	0.000176	0.00263	CbGeAlD
Amoxapine—Diarrhoea—Donepezil—Alzheimer's disease	0.000172	0.00156	CcSEcCtD
Amoxapine—Quetiapine—HTR6—Alzheimer's disease	0.000172	0.0531	CrCbGaD
Amoxapine—Dizziness—Donepezil—Alzheimer's disease	0.000166	0.00151	CcSEcCtD
Amoxapine—Asthenia—Memantine—Alzheimer's disease	0.000164	0.00149	CcSEcCtD
Amoxapine—Pruritus—Memantine—Alzheimer's disease	0.000161	0.00147	CcSEcCtD
Amoxapine—Asthenia—Rivastigmine—Alzheimer's disease	0.00016	0.00146	CcSEcCtD
Amoxapine—Vomiting—Donepezil—Alzheimer's disease	0.00016	0.00145	CcSEcCtD
Amoxapine—Rash—Donepezil—Alzheimer's disease	0.000158	0.00144	CcSEcCtD
Amoxapine—Dermatitis—Donepezil—Alzheimer's disease	0.000158	0.00144	CcSEcCtD
Amoxapine—HTR1A—brain—Alzheimer's disease	0.000158	0.00237	CbGeAlD
Amoxapine—Pruritus—Rivastigmine—Alzheimer's disease	0.000158	0.00144	CcSEcCtD
Amoxapine—Headache—Donepezil—Alzheimer's disease	0.000157	0.00143	CcSEcCtD
Amoxapine—SLC6A2—brain—Alzheimer's disease	0.000156	0.00235	CbGeAlD
Amoxapine—Diarrhoea—Memantine—Alzheimer's disease	0.000156	0.00142	CcSEcCtD
Amoxapine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000153	0.00139	CcSEcCtD
Amoxapine—HTR7—brain—Alzheimer's disease	0.000151	0.00226	CbGeAlD
Amoxapine—Dizziness—Memantine—Alzheimer's disease	0.000151	0.00137	CcSEcCtD
Amoxapine—Asenapine—HTR2A—Alzheimer's disease	0.00015	0.0463	CrCbGaD
Amoxapine—Nausea—Donepezil—Alzheimer's disease	0.000149	0.00136	CcSEcCtD
Amoxapine—Clozapine—HTR6—Alzheimer's disease	0.000148	0.0457	CrCbGaD
Amoxapine—Dizziness—Rivastigmine—Alzheimer's disease	0.000147	0.00134	CcSEcCtD
Amoxapine—HRH1—nervous system—Alzheimer's disease	0.000147	0.00221	CbGeAlD
Amoxapine—ADRA1A—brain—Alzheimer's disease	0.000145	0.00218	CbGeAlD
Amoxapine—Vomiting—Memantine—Alzheimer's disease	0.000145	0.00132	CcSEcCtD
Amoxapine—ADRA2A—nervous system—Alzheimer's disease	0.000145	0.00217	CbGeAlD
Amoxapine—Rash—Memantine—Alzheimer's disease	0.000144	0.00131	CcSEcCtD
Amoxapine—Dermatitis—Memantine—Alzheimer's disease	0.000144	0.00131	CcSEcCtD
Amoxapine—Headache—Memantine—Alzheimer's disease	0.000143	0.0013	CcSEcCtD
Amoxapine—DRD2—brain—Alzheimer's disease	0.000143	0.00214	CbGeAlD
Amoxapine—HRH1—central nervous system—Alzheimer's disease	0.000142	0.00213	CbGeAlD
Amoxapine—Vomiting—Rivastigmine—Alzheimer's disease	0.000142	0.00129	CcSEcCtD
Amoxapine—Rash—Rivastigmine—Alzheimer's disease	0.000141	0.00128	CcSEcCtD
Amoxapine—Dermatitis—Rivastigmine—Alzheimer's disease	0.00014	0.00128	CcSEcCtD
Amoxapine—Headache—Rivastigmine—Alzheimer's disease	0.00014	0.00127	CcSEcCtD
Amoxapine—ADRA2A—central nervous system—Alzheimer's disease	0.000139	0.00209	CbGeAlD
Amoxapine—Asenapine—CYP2D6—Alzheimer's disease	0.000137	0.0424	CrCbGaD
Amoxapine—ADRA2A—cerebellum—Alzheimer's disease	0.000136	0.00204	CbGeAlD
Amoxapine—Nausea—Memantine—Alzheimer's disease	0.000135	0.00123	CcSEcCtD
Amoxapine—Nausea—Rivastigmine—Alzheimer's disease	0.000132	0.00121	CcSEcCtD
Amoxapine—HTR2A—nervous system—Alzheimer's disease	0.000123	0.00185	CbGeAlD
Amoxapine—HTR2A—central nervous system—Alzheimer's disease	0.000118	0.00178	CbGeAlD
Amoxapine—HTR2A—cerebellum—Alzheimer's disease	0.000116	0.00174	CbGeAlD
Amoxapine—HRH1—brain—Alzheimer's disease	0.000113	0.00169	CbGeAlD
Amoxapine—CYP2D6—nervous system—Alzheimer's disease	0.000112	0.00168	CbGeAlD
Amoxapine—ADRA2A—brain—Alzheimer's disease	0.000111	0.00166	CbGeAlD
Amoxapine—CYP2D6—central nervous system—Alzheimer's disease	0.000108	0.00162	CbGeAlD
Amoxapine—CYP2D6—cerebellum—Alzheimer's disease	0.000105	0.00158	CbGeAlD
Amoxapine—HTR2A—brain—Alzheimer's disease	9.4e-05	0.00141	CbGeAlD
Amoxapine—Zuclopenthixol—HTR2A—Alzheimer's disease	8.74e-05	0.0271	CrCbGaD
Amoxapine—CYP2D6—brain—Alzheimer's disease	8.57e-05	0.00129	CbGeAlD
Amoxapine—Olanzapine—HTR2A—Alzheimer's disease	8.32e-05	0.0258	CrCbGaD
Amoxapine—Chlordiazepoxide—CYP2D6—Alzheimer's disease	8.13e-05	0.0252	CrCbGaD
Amoxapine—Zuclopenthixol—CYP2D6—Alzheimer's disease	7.99e-05	0.0247	CrCbGaD
Amoxapine—Olanzapine—CYP2D6—Alzheimer's disease	7.61e-05	0.0236	CrCbGaD
Amoxapine—Loxapine—SLC6A4—Alzheimer's disease	6.73e-05	0.0208	CrCbGaD
Amoxapine—Diazepam—PTGS1—Alzheimer's disease	5.91e-05	0.0183	CrCbGaD
Amoxapine—Loxapine—HTR2A—Alzheimer's disease	5.17e-05	0.016	CrCbGaD
Amoxapine—Quetiapine—HTR2A—Alzheimer's disease	5.05e-05	0.0156	CrCbGaD
Amoxapine—Quetiapine—CYP2D6—Alzheimer's disease	4.62e-05	0.0143	CrCbGaD
Amoxapine—Clozapine—HTR2A—Alzheimer's disease	4.34e-05	0.0134	CrCbGaD
Amoxapine—Clozapine—CYP2D6—Alzheimer's disease	3.97e-05	0.0123	CrCbGaD
Amoxapine—HRH1—Signaling Pathways—APOE—Alzheimer's disease	2.73e-06	3.82e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—LEP—Alzheimer's disease	2.73e-06	3.82e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—GSK3B—Alzheimer's disease	2.73e-06	3.81e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—NOS3—Alzheimer's disease	2.72e-06	3.81e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—LEP—Alzheimer's disease	2.72e-06	3.8e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—APOE—Alzheimer's disease	2.72e-06	3.8e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—CASP3—Alzheimer's disease	2.72e-06	3.8e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CREB1—Alzheimer's disease	2.72e-06	3.8e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—CASP3—Alzheimer's disease	2.72e-06	3.8e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CAV1—Alzheimer's disease	2.71e-06	3.79e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CREB1—Alzheimer's disease	2.71e-06	3.78e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—INS—Alzheimer's disease	2.71e-06	3.78e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CAV1—Alzheimer's disease	2.71e-06	3.78e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—IL6—Alzheimer's disease	2.7e-06	3.78e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—IL6—Alzheimer's disease	2.7e-06	3.78e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CAV1—Alzheimer's disease	2.7e-06	3.77e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—INS—Alzheimer's disease	2.69e-06	3.76e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CALM1—Alzheimer's disease	2.69e-06	3.76e-05	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—IL6—Alzheimer's disease	2.69e-06	3.75e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—LEP—Alzheimer's disease	2.68e-06	3.75e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—APOE—Alzheimer's disease	2.68e-06	3.75e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—HTR2A—Alzheimer's disease	2.68e-06	3.74e-05	CbGpPWpGaD
Amoxapine—HTR1B—GPCR downstream signaling—AKT1—Alzheimer's disease	2.67e-06	3.73e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CCL2—Alzheimer's disease	2.66e-06	3.72e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—ESR1—Alzheimer's disease	2.66e-06	3.71e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CAV1—Alzheimer's disease	2.65e-06	3.71e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CCL2—Alzheimer's disease	2.65e-06	3.7e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CASP3—Alzheimer's disease	2.64e-06	3.7e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—IL6—Alzheimer's disease	2.63e-06	3.67e-05	CbGpPWpGaD
Amoxapine—DRD4—GPCR downstream signaling—AKT1—Alzheimer's disease	2.63e-06	3.67e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—F2—Alzheimer's disease	2.62e-06	3.67e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IGF1—Alzheimer's disease	2.62e-06	3.66e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—ESR1—Alzheimer's disease	2.61e-06	3.65e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—ESR1—Alzheimer's disease	2.61e-06	3.64e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IGF1—Alzheimer's disease	2.6e-06	3.64e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CASP3—Alzheimer's disease	2.6e-06	3.64e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—ESR1—Alzheimer's disease	2.6e-06	3.63e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PPARG—Alzheimer's disease	2.59e-06	3.62e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—IL6—Alzheimer's disease	2.59e-06	3.61e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—F2—Alzheimer's disease	2.58e-06	3.61e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—F2—Alzheimer's disease	2.58e-06	3.6e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—F2—Alzheimer's disease	2.57e-06	3.59e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—NOTCH1—Alzheimer's disease	2.57e-06	3.59e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—ESR1—Alzheimer's disease	2.56e-06	3.58e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—INS—Alzheimer's disease	2.54e-06	3.56e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	2.54e-06	3.55e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	2.53e-06	3.54e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	2.53e-06	3.53e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—F2—Alzheimer's disease	2.53e-06	3.53e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.53e-06	3.53e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—NOTCH1—Alzheimer's disease	2.52e-06	3.52e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	2.51e-06	3.51e-05	CbGpPWpGaD
Amoxapine—HTR2B—GPCR downstream signaling—AKT1—Alzheimer's disease	2.51e-06	3.5e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—MAPK8—Alzheimer's disease	2.5e-06	3.5e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—MAPK8—Alzheimer's disease	2.5e-06	3.49e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	2.5e-06	3.49e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—AKT1—Alzheimer's disease	2.49e-06	3.49e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—AKT1—Alzheimer's disease	2.49e-06	3.48e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	2.49e-06	3.48e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	2.49e-06	3.48e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CASP3—Alzheimer's disease	2.48e-06	3.47e-05	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—AKT1—Alzheimer's disease	2.48e-06	3.46e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.47e-06	3.46e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—IL6—Alzheimer's disease	2.47e-06	3.45e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	2.47e-06	3.45e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—MAPK8—Alzheimer's disease	2.43e-06	3.4e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—AKT1—Alzheimer's disease	2.42e-06	3.39e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	2.41e-06	3.37e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—MAPK8—Alzheimer's disease	2.39e-06	3.34e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	2.39e-06	3.34e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—AKT1—Alzheimer's disease	2.39e-06	3.33e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	2.38e-06	3.32e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—INS—Alzheimer's disease	2.38e-06	3.32e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	2.37e-06	3.32e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	2.37e-06	3.31e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—GSK3B—Alzheimer's disease	2.36e-06	3.31e-05	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.36e-06	3.31e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	2.36e-06	3.3e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—GSK3B—Alzheimer's disease	2.36e-06	3.29e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	2.35e-06	3.29e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	2.35e-06	3.28e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CREB1—Alzheimer's disease	2.35e-06	3.28e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CASP3—Alzheimer's disease	2.34e-06	3.27e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CREB1—Alzheimer's disease	2.34e-06	3.27e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—INS—Alzheimer's disease	2.34e-06	3.27e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	2.34e-06	3.27e-05	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—AKT1—Alzheimer's disease	2.33e-06	3.26e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—INS—Alzheimer's disease	2.33e-06	3.26e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—IL6—Alzheimer's disease	2.33e-06	3.25e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—INS—Alzheimer's disease	2.33e-06	3.25e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	2.32e-06	3.24e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—LPL—Alzheimer's disease	2.31e-06	3.24e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CASP3—Alzheimer's disease	2.31e-06	3.23e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—VEGFA—Alzheimer's disease	2.31e-06	3.23e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—VEGFA—Alzheimer's disease	2.31e-06	3.22e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	2.3e-06	3.22e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	2.3e-06	3.21e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	2.3e-06	3.21e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.3e-06	3.21e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—IL6—Alzheimer's disease	2.3e-06	3.21e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CCL2—Alzheimer's disease	2.3e-06	3.21e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	2.29e-06	3.2e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CCL2—Alzheimer's disease	2.29e-06	3.2e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—MAPK8—Alzheimer's disease	2.28e-06	3.19e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—AKT1—Alzheimer's disease	2.28e-06	3.18e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	2.26e-06	3.16e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	2.26e-06	3.15e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	2.25e-06	3.15e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	2.25e-06	3.14e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—VEGFA—Alzheimer's disease	2.24e-06	3.14e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—NOS3—Alzheimer's disease	2.23e-06	3.12e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	2.21e-06	3.09e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—VEGFA—Alzheimer's disease	2.21e-06	3.09e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	2.16e-06	3.01e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—MAPK8—Alzheimer's disease	2.15e-06	3.01e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—AKT1—Alzheimer's disease	2.15e-06	3e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	2.14e-06	2.99e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	2.13e-06	2.97e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MAPK8—Alzheimer's disease	2.12e-06	2.97e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TGFB1—Alzheimer's disease	2.12e-06	2.96e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—AKT1—Alzheimer's disease	2.12e-06	2.96e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TGFB1—Alzheimer's disease	2.12e-06	2.96e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—VEGFA—Alzheimer's disease	2.11e-06	2.95e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	2.09e-06	2.92e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	2.08e-06	2.91e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	2.08e-06	2.91e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TGFB1—Alzheimer's disease	2.06e-06	2.88e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	2.06e-06	2.88e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	2.05e-06	2.87e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	2.05e-06	2.86e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	2.04e-06	2.85e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	2.04e-06	2.85e-05	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.03e-06	2.84e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TGFB1—Alzheimer's disease	2.03e-06	2.83e-05	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	2.02e-06	2.83e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	2.01e-06	2.82e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	2.01e-06	2.81e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	2e-06	2.8e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	2e-06	2.8e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	1.99e-06	2.78e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—VEGFA—Alzheimer's disease	1.99e-06	2.78e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—VEGFA—Alzheimer's disease	1.96e-06	2.74e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	1.95e-06	2.72e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—APOE—Alzheimer's disease	1.94e-06	2.71e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TGFB1—Alzheimer's disease	1.94e-06	2.7e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	1.92e-06	2.69e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	1.87e-06	2.61e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.85e-06	2.59e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.85e-06	2.58e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.84e-06	2.57e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.84e-06	2.57e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TGFB1—Alzheimer's disease	1.82e-06	2.55e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TGFB1—Alzheimer's disease	1.8e-06	2.52e-05	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.79e-06	2.5e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	1.77e-06	2.47e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	1.76e-06	2.46e-05	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.76e-06	2.46e-05	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.75e-06	2.45e-05	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.75e-06	2.44e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TP53—Alzheimer's disease	1.75e-06	2.44e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TP53—Alzheimer's disease	1.74e-06	2.44e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	1.74e-06	2.43e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	1.74e-06	2.43e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	1.73e-06	2.42e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	1.73e-06	2.42e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	1.73e-06	2.41e-05	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.72e-06	2.4e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	1.72e-06	2.4e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.71e-06	2.39e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	1.7e-06	2.38e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.7e-06	2.38e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TP53—Alzheimer's disease	1.7e-06	2.37e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	1.69e-06	2.37e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.69e-06	2.36e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TP53—Alzheimer's disease	1.67e-06	2.33e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—INS—Alzheimer's disease	1.66e-06	2.32e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	1.63e-06	2.27e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	1.62e-06	2.27e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.6e-06	2.24e-05	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.6e-06	2.23e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IL6—Alzheimer's disease	1.6e-06	2.23e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	1.6e-06	2.23e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IL6—Alzheimer's disease	1.6e-06	2.23e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.6e-06	2.23e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TP53—Alzheimer's disease	1.59e-06	2.23e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	1.59e-06	2.22e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	1.59e-06	2.22e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	1.59e-06	2.22e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	1.58e-06	2.21e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	1.57e-06	2.2e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.57e-06	2.19e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.57e-06	2.19e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.56e-06	2.18e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.56e-06	2.18e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IL6—Alzheimer's disease	1.55e-06	2.17e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IL6—Alzheimer's disease	1.53e-06	2.13e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TP53—Alzheimer's disease	1.5e-06	2.1e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	1.5e-06	2.1e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TP53—Alzheimer's disease	1.48e-06	2.07e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.48e-06	2.06e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	1.47e-06	2.06e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—AKT1—Alzheimer's disease	1.47e-06	2.06e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—AKT1—Alzheimer's disease	1.47e-06	2.06e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	1.47e-06	2.05e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IL6—Alzheimer's disease	1.46e-06	2.04e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.46e-06	2.03e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.45e-06	2.03e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.45e-06	2.03e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.45e-06	2.02e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—AKT1—Alzheimer's disease	1.43e-06	2e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—AKT1—Alzheimer's disease	1.41e-06	1.97e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	1.38e-06	1.93e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IL6—Alzheimer's disease	1.38e-06	1.92e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IL6—Alzheimer's disease	1.36e-06	1.9e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.36e-06	1.89e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	1.35e-06	1.89e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	1.35e-06	1.88e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—AKT1—Alzheimer's disease	1.35e-06	1.88e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.34e-06	1.88e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.33e-06	1.86e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.33e-06	1.86e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	1.29e-06	1.81e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	1.29e-06	1.8e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—AKT1—Alzheimer's disease	1.27e-06	1.77e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—AKT1—Alzheimer's disease	1.25e-06	1.75e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.23e-06	1.72e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	1.18e-06	1.65e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	1.18e-06	1.64e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TP53—Alzheimer's disease	1.13e-06	1.59e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	1.12e-06	1.56e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TP53—Alzheimer's disease	1.11e-06	1.56e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	1.11e-06	1.55e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	1.09e-06	1.53e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	1.09e-06	1.52e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	1.09e-06	1.52e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL6—Alzheimer's disease	1.04e-06	1.45e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—AKT1—Alzheimer's disease	1.03e-06	1.43e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	1.02e-06	1.43e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL6—Alzheimer's disease	1.02e-06	1.42e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	1.02e-06	1.42e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	1.02e-06	1.42e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	1e-06	1.4e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	9.58e-07	1.34e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	9.42e-07	1.32e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	9.4e-07	1.31e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	9.37e-07	1.31e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	9.29e-07	1.3e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	9.23e-07	1.29e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	8.57e-07	1.2e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	6.68e-07	9.34e-06	CbGpPWpGaD
